M&A TRANSACTION · 2025
OneOncology acquired by Cencora, Inc.
$7.40B· 19.0x EBITDA
Target
OneOncology
Acquirer
Cencora, Inc.
Strategic buyer
Disclosed financials at time of acquisition
Revenue
—
EBITDA
$389.0M
Deal Value
$7.40B
EV/EBITDA
19.0x
Context
This $7.40B acquisition of OneOncology by Cencora, Inc. sits in the medical practice specialty sub-vertical. The 19.0x EBITDA multiple paid in 2025 can be compared against the population median for medical practice specialty transactions of similar size on our Medical Practice Specialty valuation hub. Cencora, Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price medical practice specialty businesses on our Medical Practice Specialty strategic buyer-pool page.
Source
Data sourced from Press release. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical practice specialty
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the OneOncology acquisition.